The scientific rationale for developing taxoids

Anti-Cancer Drugs

Volumn 7, Issue SUPPL. 2, 1996, Pages 33-36

  Aapro, M ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

docetaxel (Taxotere ); haematopoietic cells; microtubules; plasma concentration; preclinical studies

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; MITOMYCIN; NAVELBINE; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG DEVELOPMENT; DRUG POTENTIATION; HEMATOPOIESIS; HUMAN; MICROTUBULE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL;

EID: 0029813045     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199608002-00009     Document Type: Conference Paper

References (18)

1. Lavelle F, Bissery MC, Combeau C, et al. Preclinical evaluation of docetaxel (Taxotere). Semin Oncol 1995; 22(suppl 4): 3-16.
2. Ringel I, Horwitz SB. Studies with RPR 56976 (Taxotere): a semisynthetic analogue of Taxol. J Natl Cancer Inst 1991; 83: 288-291.
3. Diaz JF, Andreu JM. Assembly of purified GDP-tubulin into microtubules induced by Taxol and Taxotere: reversibility, ligand stoichiometry, and competition. Biochemistry 1993; 32: 2747-2755.
4. Andreu JM, Bordas J, Diaz JF, at al. Low resolution structure of microtubules in solution. J Mol Biol 1992; 226: 169-184.
5. Andreu JM, Diaz JF, Gil R, et al. Solution structure of microtubules induced by the side chain Taxol analogue Taxotere to 3 nm resolution. J Biol Chem 1994; 269: 31785-31792.
6. Riou JF, Petitgenet O, Combeau C, et al. Cellular uptake and efflux of docetaxel and paclitaxel in P388 cell line [abstract]. Proc Am Assoc Cancer Res 1994; 35: 2292.
7. Riou JF, Naudin A, Lavelle F. Effects of Taxotere on murine and human tumor cell lines. Biochem Biophy Res Commun 1992; 187: 164-170.
8. Kelland LR, Abel G. Comparative in vitro cytotoxicity of Taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. Cancer Chemother Pharmacol 1992; 30: 444-450.
9. Braakhuis BJM, Hill BT, Dietel M, et al. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumors and normal bone marrow cells. Anticancer Res 1994; 14: 205-208.
10. Hanauske AR, Degen D, Hilsenbeck SG, et al. Effects of Taxotere and Taxol in vitro colony formation of freshly explanted human tumor cells. Anti-Cancer Drugs 1992; 3: 121-124.
11. Vogel M, Hilsenbeck SG, Debenbrock H, et al. Preclinical activity of Taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: comparison with Taxol and conventional antineoplastic agents. Eur J Cancer 1993; 29A: 2009-2014.
12. Bissery MC, Guénard D, Guéritte-Voegelein F, et al. Experimental antitumor activity of Taxotere (RP 56976, NSC 628503), a Taxol analogue. Cancer Res 1991; 51: 4845-4852.
13. Bissery MC, Nohynek G, Sanderink G-J, Lavelle F. Docetaxel (Taxotere®): a review of preclinical and clinical experience. Part I: preclinical experience. Anti-Cancer Drugs 1995; 6: 339-368.
14. Boven E, Venema-Gaberscek E, Erkelens CAM, et al. Antitumor activity of Taxotere (RP 56976, NSC 628503), a new Taxol analogue, in experimental ovarian cancer. Ann Oncol 1993; 4: 321-324.
15. Nicoletti MI, Lucchini V, D'Incalci M, et al. Comparison of paclitaxel and docetaxel activity on human ovarian carcinoma xenografts. EurJ Cancer 1994; 30A: 691-696.
16. Dykes DJ, Waud WR, Bissery MC. et al. Response of human tumor xenografts in athymic nude mice to Taxotere. Invest New Drugs 1995; 13: 1-11.
17. Powell CB, Mutch DG, Kao M-S et al. Dexamethasone used as an antiemetic in chemotherapy protocols inhibits natural cytotoxic (NC) cell activity. Cancer 1990; 65: 466-472.
18. Aapro MS, Serokman R, Alberts DS. Lack of dexamethasone effect on the antitumour activity of cisplatin. Cancer Treat 1983; Rep 67: 1013-1017.